{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T22:25:20Z","timestamp":1781562320429,"version":"3.54.5"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s40620-019-00618-x","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T06:02:47Z","timestamp":1559714567000},"page":"783-789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["The relationship between the concentration of plasma homocysteine and chronic kidney disease: a cross sectional study of a large cohort"],"prefix":"10.1093","volume":"32","author":[{"given":"Eytan","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ili","family":"Margalit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzippy","family":"Shochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"key":"618_CR1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/jcp.17.4.427","volume":"17","author":"JB Gibson","year":"1964","unstructured":"Gibson JB, Carson NA, Neill DW (1964) Pathological findings in homocystinuria. J Clin Pathol 17:427\u2013437","journal-title":"J Clin Pathol"},{"key":"618_CR2","first-page":"111","volume":"56","author":"KS McCully","year":"1969","unstructured":"McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111\u2013128","journal-title":"Am J Pathol"},{"key":"618_CR3","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","volume":"285","author":"PM Ridker","year":"2001","unstructured":"Ridker PM, Stampfer MJ, Rifai N (2001) Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285:2481\u20132485","journal-title":"JAMA"},{"key":"618_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","volume":"268","author":"MJ Stampfer","year":"1992","unstructured":"Stampfer MJ, Malinow MR, Willett WC et al (1992) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268:877\u2013881","journal-title":"JAMA"},{"key":"618_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S0002-8703(00)90088-7","volume":"139","author":"WH Giles","year":"2000","unstructured":"Giles WH, Croft JB, Greenlund KJ, Ford ES, Kittner SJ (2000) Association between total homocyst(e)ine and the likelihood for a history of acute myocardial infarction by race and ethnicity: results from the Third National Health and Nutrition Examination Survey. Am Heart J 139:446\u2013453","journal-title":"Am Heart J"},{"key":"618_CR6","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0735-1097(00)00820-2","volume":"36","author":"MK Al-Obaidi","year":"2000","unstructured":"Al-Obaidi MK, Stubbs PJ, Collinson P et al (2000) Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes. J Am Coll Cardiol 36:1217\u20131222","journal-title":"J Am Coll Cardiol"},{"key":"618_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.7326\/0003-4819-140-2-200401200-00009","volume":"140","author":"M Soinio","year":"2004","unstructured":"Soinio M, Marniemi J, Laakso M, Lehto S, Ronnemaa T (2004) Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Intern Med 140:94\u2013100","journal-title":"Ann Intern Med"},{"key":"618_CR8","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1017\/S0007114510001236","volume":"104","author":"CJ Bates","year":"2010","unstructured":"Bates CJ, Mansoor MA, Pentieva KD, Hamer M, Mishra GD (2010) Biochemical risk indices, including plasma homocysteine, that prospectively predict mortality in older British people: the National Diet and Nutrition Survey of People Aged 65 Years and Over. Br J Nutr 104:893\u2013899","journal-title":"Br J Nutr"},{"key":"618_CR9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3949\/ccjm.77a.10036","volume":"77","author":"JM Abraham","year":"2010","unstructured":"Abraham JM, Cho L (2010) The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease? Cleve Clin J Med 77:911\u2013918","journal-title":"Cleve Clin J Med"},{"key":"618_CR10","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJMoa060900","volume":"354","author":"E Lonn","year":"2006","unstructured":"Lonn E, Yusuf S, Arnold MJ et al (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354:1567\u20131577","journal-title":"N Engl J Med"},{"key":"618_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1001\/jama.288.8.973","volume":"288","author":"G Schnyder","year":"2002","unstructured":"Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM (2002) Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA 288:973\u2013979","journal-title":"JAMA"},{"key":"618_CR12","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1056\/NEJMoa032845","volume":"350","author":"H Lange","year":"2004","unstructured":"Lange H, Suryapranata H, De Luca G et al (2004) Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med 350:2673\u20132681","journal-title":"N Engl J Med"},{"key":"618_CR13","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1681\/ASN.2005010112","volume":"16","author":"DT Gilbertson","year":"2005","unstructured":"Gilbertson DT, Liu J, Xue JL et al (2005) Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 16:3736\u20133741","journal-title":"J Am Soc Nephrol"},{"key":"618_CR14","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/eurheartj\/eht090","volume":"34","author":"GM Frohlich","year":"2013","unstructured":"Frohlich GM, Meier P, White SK, Yellon DM, Hausenloy DJ (2013) Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J 34:1714\u20131722","journal-title":"Eur Heart J"},{"key":"618_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1523-1755.2004.00732.x","volume":"66","author":"ME Francis","year":"2004","unstructured":"Francis ME, Eggers PW, Hostetter TH, Briggs JP (2004) Association between serum homocysteine and markers of impaired kidney function in adults in the United States. Kidney Int 66:303\u2013312","journal-title":"Kidney Int"},{"key":"618_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1159\/000355722","volume":"37","author":"CH Chuang","year":"2013","unstructured":"Chuang CH, Lee YY, Sheu BF et al (2013) Homocysteine and C-reactive protein as useful surrogate markers for evaluating CKD risk in adults. Kidney Blood Press Res 37:402\u2013413","journal-title":"Kidney Blood Press Res"},{"key":"618_CR17","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1006\/bbrc.2000.3723","volume":"277","author":"T Togawa","year":"2000","unstructured":"Togawa T, Sengupta S, Chen H et al (2000) Mechanisms for the formation of protein-bound homocysteine in human plasma. Biochem Biophys Res Commun 277:668\u2013674","journal-title":"Biochem Biophys Res Commun"},{"key":"618_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1046\/j.1523-1755.1998.00983.x","volume":"54","author":"C van Guldener","year":"1998","unstructured":"van Guldener C, Donker AJ, Jakobs C et al (1998) No net renal extraction of homocysteine in fasting humans. Kidney Int 54:166\u2013169","journal-title":"Kidney Int"},{"key":"618_CR19","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1515\/CCLM.2003.217","volume":"41","author":"C van Guldener","year":"2003","unstructured":"van Guldener C, Stehouwer CD (2003) Homocysteine metabolism in renal disease. Clin Chem Lab Med 41:1412\u20131417","journal-title":"Clin Chem Lab Med"},{"key":"618_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3949\/ccjm.64.10.543","volume":"64","author":"RS Ballal","year":"1997","unstructured":"Ballal RS, Jacobsen DW, Robinson K (1997) Homocysteine: update on a new risk factor. Cleve Clin J Med 64:543\u2013549","journal-title":"Cleve Clin J Med"},{"key":"618_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"618_CR22","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(03)13372-7","volume":"361","author":"D Ingrosso","year":"2003","unstructured":"Ingrosso D, Cimmino A, Perna AF et al (2003) Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 361:1693\u20131699","journal-title":"Lancet"},{"key":"618_CR23","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.ejim.2014.10.014","volume":"25","author":"A Levi","year":"2014","unstructured":"Levi A, Cohen E, Levi M et al (2014) Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: a historical prospective study. Eur J Intern Med 25:951\u2013955","journal-title":"Eur J Intern Med"},{"key":"618_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0272-6386(04)00813-3","volume":"44","author":"T Ninomiya","year":"2004","unstructured":"Ninomiya T, Kiyohara Y, Kubo M et al (2004) Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study. Am J Kidney Dis 44:437\u2013445","journal-title":"Am J Kidney Dis"},{"key":"618_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.biochi.2016.04.018","volume":"126","author":"AF Perna","year":"2016","unstructured":"Perna AF, Di Nunzio A, Amoresano A et al (2016) Divergent behavior of hydrogen sulfide pools and of the sulfur metabolite lanthionine, a novel uremic toxin, in dialysis patients. Biochimie 126:97\u2013107","journal-title":"Biochimie"},{"key":"618_CR26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/ndt\/gfv380","volume":"31","author":"JD Spence","year":"2016","unstructured":"Spence JD, Urquhart BL, Bang H (2016) Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine. Nephrol Dial Transpl 31:937\u2013944","journal-title":"Nephrol Dial Transpl"},{"key":"618_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1525-139X.2009.00579.x","volume":"22","author":"AF Perna","year":"2009","unstructured":"Perna AF, Ingrosso D, Violetti E et al (2009) Hyperhomocysteinemia in uremia\u2013a red flag in a disrupted circuit. Semin Dial 22:351\u2013356","journal-title":"Semin Dial"},{"key":"618_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1023\/A:1022130217463","volume":"16","author":"WG Haynes","year":"2002","unstructured":"Haynes WG (2002) Hyperhomocysteinemia, vascular function and atherosclerosis: effects of vitamins. Cardiovasc Drugs Ther 16:391\u2013399","journal-title":"Cardiovasc Drugs Ther"},{"key":"618_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1046\/j.1523-1755.1998.00968.x","volume":"54","author":"A Meyrier","year":"1998","unstructured":"Meyrier A, Hill GS, Simon P (1998) Ischemic renal diseases: new insights into old entities. Kidney Int 54:2\u201313","journal-title":"Kidney Int"},{"key":"618_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/nu11020383","author":"I Capelli","year":"2019","unstructured":"Capelli I, Cianciolo G, Gasperoni L et al (2019) Folic acid and vitamin B12 administration in CKD, why not? Nutrients. \n                    https:\/\/doi.org\/10.3390\/nu11020383","journal-title":"Nutrients"},{"key":"618_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000471813","volume":"7","author":"G Cianciolo","year":"2017","unstructured":"Cianciolo G, De Pascalis A, Di Lullo L et al (2017) Folic acid and homocysteine in chronic kidney disease and cardiovascular disease progression: which comes first? Cardiorenal Med 7:255\u2013266","journal-title":"Cardiorenal Med"},{"key":"618_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/ajcn\/57.1.47","volume":"57","author":"JB Ubbink","year":"1993","unstructured":"Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ (1993) Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 57:47\u201353","journal-title":"Am J Clin Nutr"},{"key":"618_CR33","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/jamainternmed.2016.4687","volume":"176","author":"X Xu","year":"2016","unstructured":"Xu X, Qin X, Li Y et al (2016) Efficacy of folic acid therapy on the progression of chronic kidney disease: the renal substudy of the china stroke primary prevention trial. JAMA Intern Med 176:1443\u20131450","journal-title":"JAMA Intern Med"},{"key":"618_CR34","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","volume":"298","author":"RL Jamison","year":"2007","unstructured":"Jamison RL, Hartigan P, Kaufman JS et al (2007) Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 298:1163\u20131170","journal-title":"JAMA"},{"key":"618_CR35","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1001\/jama.2010.490","volume":"303","author":"AA House","year":"2010","unstructured":"House AA, Eliasziw M, Cattran DC et al (2010) Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 303:1603\u20131609","journal-title":"JAMA"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-019-00618-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-019-00618-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-019-00618-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:09Z","timestamp":1777564569000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/32\/5\/783\/8328161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1007\/s40620-019-00618-x","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,5]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed involving human participants were in accordance with the ethical standards of the Helsinki Ethics Committee of Rabin Medical Center, Israel and in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Since all the ID numbers of all the participants were changed into coded numbers before any analysis was performed, the Helsinki Ethics Committee of the Rabin center did not request an informed consent from the participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}